Stocks News

LAST PRICE
58.8800
TODAY'S CHANGE (%)
Trending Up0.1000 (0.1701%)

Bid / Lots
58.6200/ 2
Ask / Lots
59.6000/ 1
Open / Previous Close
58.5100 / 58.7800
Day Range
Low 58.3900
High 58.9800
52 Week Range
Low 36.7387
High 61.2000
Volume
1,097,719
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 8, 2024
- Novo Nordisk Earnings Ease Investor Concerns, Put Focus on New Obesity Drug Trial, from 10:45AM ET on Friday Nov 08, 2024 by MT Newswires
  10:45AM ET on Friday Nov 08, 2024 by MT Newswires
  Companies Mentioned: LLY, NVO, CTLT
  10:45 AM EST, 11/08/2024 (MT Newswires) -- Novo Nordisk's (NVO) third-quarter earnings were solid enough to soothe investor jitters and turn the market's attention toward upcoming trial results for a potentially game-changing new weight-loss drug, a...
Nov 5, 2024
- Catalent Fiscal Q1 Net Loss Flat, Revenue Gains, from 8:25AM ET on Tuesday Nov 05, 2024 by MT Newswires
  8:25AM ET on Tuesday Nov 05, 2024 by MT Newswires
  Companies Mentioned: CTLT
  08:25 AM EST, 11/05/2024 (MT Newswires) -- Catalent (CTLT) reported a fiscal Q1 adjusted net loss Tuesday of $0.13 per diluted share, unchanged from a year ago. Three analysts polled by Capital IQ expected adjusted earnings of $0.10. Net revenue for...
- -- Earnings Flash (CTLT) CATALENT Reports Q1 Revenue $1.02B, from 7:02AM ET on Tuesday Nov 05, 2024 by MT Newswires
  7:02AM ET on Tuesday Nov 05, 2024 by MT Newswires
  Companies Mentioned: CTLT
  07:02 AM EST, 11/05/2024 (MT Newswires) -- ...
- *DJ Catalent 1Q Rev $1.02B >CTLT, from 7:00AM ET on Tuesday Nov 05, 2024 by Dow Jones
  7:00AM ET on Tuesday Nov 05, 2024 by Dow Jones
  Companies Mentioned: CTLT
  
  View source version on businesswire.com: https://www.businesswire.com/news/home/20241105555610/en/
  CONTACT: Investor Contact:
  Catalent, Inc.
  
  Paul Surdez
- Catalent, Inc. Reports First Quarter Fiscal 2025 Results, from 7:00AM ET on Tuesday Nov 05, 2024 by Dow Jones
  7:00AM ET on Tuesday Nov 05, 2024 by Dow Jones
  Companies Mentioned: CTLT
  
  View source version on businesswire.com: https://www.businesswire.com/news/home/20241105555610/en/
  CONTACT: Investor Contact:
  Catalent, Inc.
  
  Paul Surdez

Today
- Jazz Pharmaceuticals to Participate in Citi's 2024 Global Healthcare Conference, from 7 hours ago by PR Newswire
  7 hours ago by PR Newswire
  Companies Mentioned: JAZZ
- Jazz Pharmaceuticals to Participate in Citi's 2024 Global Healthcare Conference, from 7 hours ago by Dow Jones
  7 hours ago by Dow Jones
  Companies Mentioned: JAZZ
- UBS Raises Price Target on Jazz Pharmaceuticals Public to $128 From $121, Maintains Neutral Rating, from 12 hours ago by MT Newswires
  12 hours ago by MT Newswires
  Companies Mentioned: JAZZ
Yesterday
- DJ Jazz Pharmaceuticals Is Maintained at Outperform by Baird, from 7:44AM ET on Monday Nov 18, 2024 by Dow Jones
  7:44AM ET on Monday Nov 18, 2024 by Dow Jones
  Companies Mentioned: JAZZ
Nov 14, 2024
- Royalty Pharma Announces Inaugural Prize for Impact in Healthcare, from 4:30PM ET on Thursday Nov 14, 2024 by Dow Jones
  4:30PM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: RPRX
Nov 13, 2024
- Jazz Pharmaceuticals Insider Sold Shares Worth $456,617, According to a Recent SEC Filing, from 5:46PM ET on Wednesday Nov 13, 2024 by MT Newswires
  5:46PM ET on Wednesday Nov 13, 2024 by MT Newswires
  Companies Mentioned: JAZZ
Nov 7, 2024
- DJ Jazz Pharmaceuticals Is Maintained at Buy by TD Cowen, from 3:08PM ET on Thursday Nov 07, 2024 by Dow Jones
  3:08PM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: JAZZ
- Geron Secures up to $375 Million in Funding with Royalty Pharma, Pharmakon Advisors, from 11:42AM ET on Thursday Nov 07, 2024 by MT Newswires
  11:42AM ET on Thursday Nov 07, 2024 by MT Newswires
  Companies Mentioned: GERN, RPRX
- DJ Jazz Pharmaceuticals Price Target Maintained With a $207.00/Share by Needham, from 8:19AM ET on Thursday Nov 07, 2024 by Dow Jones
  8:19AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: JAZZ
- Royalty Pharma to Acquire Royalty Interest in Geron's RYTELO for $125 Million, from 7:10AM ET on Thursday Nov 07, 2024 by Dow Jones
  7:10AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: GERN, RPRX

Catalent Inc
NYSE:CTLTUnited States

Search Criteria

Nov 8, 2024

Novo Nordisk Earnings Ease Investor Concerns, Put Focus on New Obesity Drug Trial, from 10:45AM ET on Friday Nov 08, 2024 by MT Newswires

Nov 5, 2024

Catalent Fiscal Q1 Net Loss Flat, Revenue Gains, from 8:25AM ET on Tuesday Nov 05, 2024 by MT Newswires

-- Earnings Flash (CTLT) CATALENT Reports Q1 Revenue $1.02B, from 7:02AM ET on Tuesday Nov 05, 2024 by MT Newswires

*DJ Catalent 1Q Rev $1.02B >CTLT, from 7:00AM ET on Tuesday Nov 05, 2024 by Dow Jones

Catalent, Inc. Reports First Quarter Fiscal 2025 Results, from 7:00AM ET on Tuesday Nov 05, 2024 by Dow Jones

Peers Headlines

Today

Jazz Pharmaceuticals to Participate in Citi's 2024 Global Healthcare Conference, from 7 hours ago by PR Newswire

Jazz Pharmaceuticals to Participate in Citi's 2024 Global Healthcare Conference, from 7 hours ago by Dow Jones

UBS Raises Price Target on Jazz Pharmaceuticals Public to $128 From $121, Maintains Neutral Rating, from 12 hours ago by MT Newswires

Yesterday

DJ Jazz Pharmaceuticals Is Maintained at Outperform by Baird, from 7:44AM ET on Monday Nov 18, 2024 by Dow Jones

Nov 14, 2024

Royalty Pharma Announces Inaugural Prize for Impact in Healthcare, from 4:30PM ET on Thursday Nov 14, 2024 by Dow Jones

Nov 13, 2024

Jazz Pharmaceuticals Insider Sold Shares Worth $456,617, According to a Recent SEC Filing, from 5:46PM ET on Wednesday Nov 13, 2024 by MT Newswires

Nov 7, 2024

DJ Jazz Pharmaceuticals Is Maintained at Buy by TD Cowen, from 3:08PM ET on Thursday Nov 07, 2024 by Dow Jones

Geron Secures up to $375 Million in Funding with Royalty Pharma, Pharmakon Advisors, from 11:42AM ET on Thursday Nov 07, 2024 by MT Newswires

DJ Jazz Pharmaceuticals Price Target Maintained With a $207.00/Share by Needham, from 8:19AM ET on Thursday Nov 07, 2024 by Dow Jones

Royalty Pharma to Acquire Royalty Interest in Geron's RYTELO for $125 Million, from 7:10AM ET on Thursday Nov 07, 2024 by Dow Jones